MYC, Metabolism, and Cancer.
By Zachary E. Stine, Z. Walton, B. Altman, Annie L Hsieh, C. V. Dang. Cancer Discovery, 2015
1,111 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/0374274e770f3d47b59be1d552da44d29560f1b0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Huafeng Zhang
- Navdeep S. Chandel
- Ralph J. Deberardinis
- Ping Gao
- Linchong Sun
- C. V. Dang
- M. V. Vander Heiden
- Craig B. Thompson
In Molecular Biology
- Huafeng Zhang
- Navdeep S. Chandel
- Ralph J. Deberardinis
- Ping Gao
- Linchong Sun
- Wenyi Wei
- Lei Chen
- T. Meng
Citations in the corpus
- The role of ubiquitination in tumorigenesis and targeted drug discovery (2020, background): “Among them, hypoxia-inducible factor-1α (HIF1α), Myc and p53 are closely related to cell metabolism.(151,187,188)”
- Metabolic reprogramming and epigenetic modifications on the path to cancer (2021, background): “…et al., 2017), von Hippel-Lindau tumor suppressor (VHL) (Herman et al., 1994; Schmitt et al., 2009; Vanharanta et al., 2013), Myc (Dang, 2012; Stine et al., 2015; Poole and van Riggelen, 2017; Topper et al., 2017; Poli et al., 2018; Li et al., 2020), p53 (Vrba et al., 2008; Su et al., 2009;…”
- Fundamentals of cancer metabolism (2016, background): “MYC increases the expression of many genes that support anabolic growth, including transporters and enzymes involved in glycolysis, fatty acid synthesis, glutaminolysis, serine metabolism, and mitochondrial metabolism (18).”